Data Safety Monitoring Board Recommends Continuation of pSivida's (PSDV) Phase III Trials for Iluvien
Tweet Send to a Friend
pSivida Corp. (NASDAQ: PSDV) today reported that an independent Data Safety Monitoring Board has recommended the continuation of two pivotal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
